Tenaya Therapeutics (TNYA) Treasury Shares (2020 - 2026)

Tenaya Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• On a quarterly basis, Treasury Shares rose 10.85% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 10.85% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 13.44% from the prior year.
• Treasury Shares grew to $2.5 million in Q1 2026 per TNYA's latest filing, from $1.5 million in the prior quarter.
• Across five years, Treasury Shares topped out at $2.5 million in Q1 2026 and bottomed at $61537.0 in Q3 2022.
• The 5-year median for Treasury Shares is $1.4 million (2024), against an average of $1.3 million.
• Across the five-year window, Treasury Shares sank 99.72% in 2022 and soared 1763.53% in 2023, its largest moves.
• Year by year, Treasury Shares stood at $459192.0 in 2022, then soared by 137.0% to $1.1 million in 2023, then gained by 24.43% to $1.4 million in 2024, then rose by 13.44% to $1.5 million in 2025, then soared by 63.9% to $2.5 million in 2026.
• Per Business Quant, the three latest TNYA Treasury Shares figures stand at $2.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.7 million (Q3 2025).